The Obesity Gold Rush Hits a Pricing Wall
The market for weight-loss drugs is rapidly evolving.
Tag: pharmaceuticals
Why the SK Capital Acquisition of Swixx Biopharma Might Be a Value Trap
Private equity is shifting towards Swiss drug distribution investments.
Can Najat Khan Salvage the Recursion Map Before the Cash Runs Dry?
Recursion Pharmaceuticals undergoes a leadership change amid AI challenges.
Why the Worlds Largest Wealth Fund Just Bet Against the Novo Nordisk Boardroom
Norway’s wealth fund is opposing changes to Novo Nordisk’s board.
Can the Two Thousand Dollar Medicare Cap Break Big Pharma Profits
U.S. pharmaceutical policy changes impact global markets significantly.
Bristol Myers Squibb and the Billion Dollar Schizophrenia Bet
Bristol-Myers Squibb’s strong earnings highlight market misvaluation.
The Metabolic Moat Faces Its Fiscal Reckoning
Eli Lilly is poised for potential growth in the upcoming quarter.
Trump Administration Considers Quantum Investments as Alphabet Stays in Focus
The Trump administration is exploring quantum technology investments.